234 related articles for article (PubMed ID: 24336083)
21. Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.
Jung CR; Lim JH; Choi Y; Kim DG; Kang KJ; Noh SM; Im DS
J Clin Invest; 2010 Dec; 120(12):4493-506. PubMed ID: 21060154
[TBL] [Abstract][Full Text] [Related]
22. p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells.
Aneja R; Ghaleb AM; Zhou J; Yang VW; Joshi HC
Cancer Res; 2007 Apr; 67(8):3862-70. PubMed ID: 17440101
[TBL] [Abstract][Full Text] [Related]
23. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
24. Ribosomal stress induces L11- and p53-dependent apoptosis in mouse pluripotent stem cells.
Morgado-Palacin L; Llanos S; Serrano M
Cell Cycle; 2012 Feb; 11(3):503-10. PubMed ID: 22262176
[TBL] [Abstract][Full Text] [Related]
25. Ligand-dependent corepressor (LCoR) recruitment by Kruppel-like factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene.
Calderon MR; Verway M; An BS; DiFeo A; Bismar TA; Ann DK; Martignetti JA; Shalom-Barak T; White JH
J Biol Chem; 2012 Mar; 287(12):8662-74. PubMed ID: 22277651
[TBL] [Abstract][Full Text] [Related]
26. p53-mediated heterochromatin reorganization regulates its cell fate decisions.
Mungamuri SK; Benson EK; Wang S; Gu W; Lee SW; Aaronson SA
Nat Struct Mol Biol; 2012 Apr; 19(5):478-84, S1. PubMed ID: 22466965
[TBL] [Abstract][Full Text] [Related]
27. Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.
Amir S; Ma AH; Shi XB; Xue L; Kung HJ; Devere White RW
PLoS One; 2013; 8(4):e61064. PubMed ID: 23585871
[TBL] [Abstract][Full Text] [Related]
28. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
29. Tumour supressor secreted frizzled related protein 1 regulates p53-mediated apoptosis.
Gauger KJ; Schneider SS
Cell Biol Int; 2014 Jan; 38(1):124-30. PubMed ID: 24038862
[TBL] [Abstract][Full Text] [Related]
30. ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation.
Sashida G; Liu Y; Elf S; Miyata Y; Ohyashiki K; Izumi M; Menendez S; Nimer SD
Mol Cell Biol; 2009 Jul; 29(13):3687-99. PubMed ID: 19380490
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.
Xu C; Fan CD; Wang X
Oncogene; 2015 Jan; 34(3):281-9. PubMed ID: 24413081
[TBL] [Abstract][Full Text] [Related]
32. MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas.
Song Y; Zhang L; Jiang Y; Hu T; Zhang D; Qiao Q; Wang R; Wang M; Han S
Theranostics; 2019; 9(20):6019-6030. PubMed ID: 31534534
[No Abstract] [Full Text] [Related]
33. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.
Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM
Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697
[TBL] [Abstract][Full Text] [Related]
34. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK
Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207
[TBL] [Abstract][Full Text] [Related]
35. A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene.
Koh DI; Choi WI; Jeon BN; Lee CE; Yun CO; Hur MW
J Biol Chem; 2009 Jul; 284(30):19856-66. PubMed ID: 19491398
[TBL] [Abstract][Full Text] [Related]
36. Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels.
Tucker CA; Kapanen AI; Chikh G; Hoffman BG; Kyle AH; Wilson IM; Masin D; Gascoyne RD; Bally M; Klasa RJ
Mol Cancer Ther; 2008 Apr; 7(4):749-58. PubMed ID: 18375822
[TBL] [Abstract][Full Text] [Related]
37. Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation.
Jabbour AM; Daunt CP; Green BD; Vogel S; Gordon L; Lee RS; Silke N; Pearson RB; Vandenberg CJ; Kelly PN; Nutt SL; Strasser A; Borner C; Ekert PG
Blood; 2010 Jan; 115(2):344-52. PubMed ID: 19965665
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
Kai L; Samuel SK; Levenson AS
Int J Cancer; 2010 Apr; 126(7):1538-48. PubMed ID: 19810103
[TBL] [Abstract][Full Text] [Related]
39. Mdm2 RING mutation enhances p53 transcriptional activity and p53-p300 interaction.
Clegg HV; Itahana Y; Itahana K; Ramalingam S; Zhang Y
PLoS One; 2012; 7(5):e38212. PubMed ID: 22666487
[TBL] [Abstract][Full Text] [Related]
40. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
